Introduction
Obstructive sleep apnea (OSA) is a disorder characterized by short apneas or hypopneas during sleep. These pauses in breathing lead to disruption of sleep and hypoxemia. The diagnosis could be done by polysomnography or by a home sleep apnea study at home [1] . If untreated, sleep apnea may aggravate or even cause a variety of diseases, such as cardiovascular and metabolic diseases [2, 3] . The current treatment for sleep apnea, along with lifestyle counseling, is positive airway pressure (PAP) treatment. PAP uses positive pressure to assist the patient's own breathing and helps keep the airway open during sleep [3, 4] PAP treatment is administered via a mask that is worn while sleeping [5] . The treatment is generally not well tolerated, mainly due to discomfort [6] .
There are few studies regarding eye symptoms with PAP therapy. Hayirci et al showed an increase in Nelson classification of squamous metaplasia score and in Schirmer 1 score in the right eye with short-term PAP therapy [7] . A case study by Harrison et al showed three patients that experienced dryness and irritation of the eyes after PAP initiation [8] .
Conversely, Kadyan et al [9] showed that in obstructive sleep apnea patients the continuous use of PAP diminishes ocular symptoms and improves tear film compared to non-users, mainly due to better sleeping habits and posture. Acar et al [10] showed similar findings with long-term use. There are also sporadic reports of eye symptoms caused by air regurgitation through the nasolacrimal system with PAP use [11] [12] [13] .
In this pilot study, we evaluated eye symptoms before PAP initiation, a few days after PAP initiation and at 2-3 months of PAP therapy. We were interested in determining if there was any change in eye symptoms during PAP therapy.
Methods
Sleep apnea patients referred to our Sleep Unit for PAP initiation were asked to complete a questionnaire about their eye symptoms at baseline, 3-5 days after initiation and at 2-3 months of PAP therapy. Our unit is a tertiary referral centre for obstructive sleep apnea.
For each patient, our sleep nurses carefully selected the most suitable mask interface and checked for a possible disturbing leak before starting PAP therapy. Furthermore our nurses observed the patients' facial shapes and verified the direction of the intentional air leak emerging from the vent before choosing the best suitable mask.
The questionnaire consisted of four questions: A patient was considered PAP adherent if the use of PAP therapy was 4 hours or more per day. Conversely, a patient was considered non-adherent if the use was under 4 hours.
We used the age-adjusted Charlson comorbidity index (CCI) to evaluate comorbidity.
This index encompasses 19 medical conditions weighted from 1 to 6 with total scores ranging from 0 to 37 (0 = no comorbidity) [14] . 
Statistics
Results were generated using a computerized statistical package (IBM SPSS® Statistics 21.0, Armonk, NY, USA). Data was checked for normality using Shapiro-Wilk methods.
All p-values were two-sided, and the significance level was set at 0.05 throughout. Eye symptoms at baseline and with PAP were compared using paired t-test when applicable.
ANOVA and Chi test were used when appropriate. We also used the bivariate Pearson correlation.
Results
We included 46 patients (14 women). Mean age ± SD was 56.0 ± 15.9, mean BMI 31.7 ± 6.0, mean AHI 34.1 ± 21.8, mean ODI3 34.4 ± 20.7, mean oxygen saturation 91.6 ± 2.9, mean nadir SpO2 79.1 ± 8.2%, mean CT90% (cumulative time with SpO2 under 90%) 20.9 ± 26.8 and mean CCI 1.8 ± 2.3 ( Table 1) . Out of the 46 participants, 45 answered the questionnaire at baseline, 39 at four days and 24 at two months.
Dry eye symptom values
The mean ± SD dry eye symptom values at baseline were 27.5 ± 26.6, at four days of PAP therapy 28.7 ± 26.0 and at two months 30.0 ± 28.2. We did not find a significant Four patients reported previous eyelid surgery; eye symptoms in these patients did not differ from the rest of the study population. 
Mask type and brand
Six patients initially used nasal pillow masks, 34 patients used nasal masks and for six patients a full face mask was chosen. Four patients had F&P masks and the rest had Resmed masks. All patients had an additional humidifier. For two patients, we switched their nasal mask to a full face mask to reduce mouth air leak. We did not find any significant difference in eye symptoms related to the type or the brand of the mask at baseline, at four days or two months of PAP use. We also did not find any difference in the 95 th percentile of mask leak between mask types.
PAP adherence
Non-adherent PAP patients had significantly higher dry eye symptom values at baseline We also found a similar difference in the watering values at two months of PAP therapy in these groups: 32.6 ± 27.3 (non-adherent) vs. 12. differ from the rest of the subjects.
Discussion
In this pilot study, we found no significant change in the patient eye symptoms with shortterm PAP therapy.
Hayirci et al [7] have reported an increase in ocular irritation, tear evaporation and squamous metaplasia in the conjunctiva of the patients' right and left eyes with short-term CPAP therapy. The authors suggested that their observations may be due to a contact between the mask and the ocular surface, or dislocation or misplacement (or both) of the PAP mask leading to air leak. We believe that air leak from the mask directed to the eyes, intentional or unintentional, may play a major role in exacerbating or causing eye symptoms. In this study, we observed some correlation between mask leak and severity of eye watering.
We found no significant differences in eye symptoms related to the type of PAP mask used. We have previously reported that a disturbing air leak is not correlated to the amount of measured leak [15] . Leaks directed to the eye area may induce eye symptoms during PAP therapy. To avoid this problem, our sleep nurses carefully selected the most suitable mask interface for each patient and checked for a possible disturbing leak before starting PAP therapy. The nurses took in consideration the direction of the intentional air leak emerging from the vent and the patients' facial shapes. We believe that these precautions could in part explain the absence of change in eye symptoms during this study and also the absence of differences in mask leak between those who discontinued PAP therapy and those who continued PAP therapy.
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Our results agree with the findings of Kadyan et al. [9] . The authors reported amelioration in ocular symptoms and improvement in tear film with continuous PAP therapy compared to no therapy. They explained that these changes were due to better sleeping habits and sleeping posture. We do not have an explanation for this finding, meanwhile we noticed that our adherent PAP patients had significantly lower dry eye symptom values than the other patients.
Seven of our patients regularly used artificial tears, indicating the existence of dry eye disease in 15% of our studied sleep apnea patients referred for PAP therapy. We found no comparison values for this reported percentage in the literature. In the general population, the prevalence of dry eye disease varies between 5 and 35% [16] [17] [18] . The real prevalence of dry eye disease among sleep apnea patients is unknown. Nevertheless, Hsiao et al., [19] have studied subjects without sleep apnea but suffering from sleep disorders. These researchers reported a higher prevalence of Sjögren syndrome in the subjects with sleep disorders than in those without. We believe that sleep apnea patients suffer more often from dry eye disease than the general population. This possibility needs to be confirmed in the future.
Limitations of the study Our study has some limitations. As this is a pilot study, no statistical power calculations were done. Our follow-up time was relatively short (two months). We have previously reported cases of eye symptoms evolving years after PAP initiation [11] . We did not measure eye symptoms objectively, an ophthalmologist did not examine the patients and we did not explore the presence of floppy eyelid syndrome, as this syndrome is usually associated with sleep apnea and constitutes as a common cause of ocular irritation [20, 21] .
Future perspectives
Future studies should include a larger number of patients for a longer period of time.
Objective testing for dry eye disease should also be performed. 
Informed consent
Informed consent was obtained from all individual participants included in the study. 
